Loans and Allowance for Credit Losses on Loans | Note 4: Loans and Allowance for Credit Losses on Loans Loans that management has the intent and ability to hold for the foreseeable future or until maturity or payoff are reported at their outstanding principal balances adjusted for unearned income, charge-offs, the ACL-Loans, any unamortized deferred fees or costs on originated loans and unamortized premiums or discounts on purchased loans. For loans at amortized cost, interest income is accrued based on the unpaid principal balance. The Company has made a policy election to exclude accrued interest from the amortized cost basis of loans and reports accrued interest separately from the related loan balance in the consolidated balance sheets. Accrued interest on loans totaled $18.0 million and $15.4 million at June 30, 2022 and December 31, 2021, respectively. The Company also elected not to measure an allowance for credit losses for accrued interest receivables. The accrual of interest on loans is discontinued at the time the loan is 90 days past due unless the credit is well-secured and in process of collection. Past-due status is based on contractual terms of the loan. In all cases, loans are placed on nonaccrual or charged off at an earlier date if collection of principal or interest is considered doubtful. All interest accrued but not collected for loans that are placed on nonaccrual or charged off is reversed against interest income. The interest collected on these loans is applied to the principal balance until the loan can be returned to an accrual status. Loans are returned to accrual status when all the principal and interest amounts contractually due are brought current and future payments are reasonably assured. For all loan portfolio segments, the Company promptly charges off loans, or portions thereof, when available information confirms that specific loans are uncollectable based on information that includes, but is not limited to, (1) the deteriorating financial condition of the borrower, (2) declining collateral values, and/or (3) legal action, including bankruptcy, that impairs the borrower’s ability to adequately meet its obligations. When cash payments for accrued interest are received on nonaccrual loans in each loan class, the Company records a reduction in principle on the balance of the loan. Troubled debt restructured loans recognize interest income on an accrual basis at the renegotiated rate if the loan is in compliance with the modified terms. The Company offers warehouse lines of credit to fund mortgage loans held for sale from closing until sale to an investor. Under a warehousing arrangement the Company funds a mortgage loan as secured financing. The warehousing arrangement is secured by the underlying mortgages and a combination of deposits, personal guarantees and advance rates. The Company typically holds the collateral until it is sent under a bailee arrangement instructing the investor to send proceeds to the Company. Typical investors are large financial institutions or government agencies. Interest earned from the time of funding to the time of sale is recognized as interest income as accrued. Fees earned agreements are recognized when collected as noninterest income. Loan Portfolio Summary Loans receivable at June 30, 2022 and December 31, 2021 include: June 30, December 31, 2022 2021 (In thousands) Mortgage warehouse lines of credit $ 900,585 $ 781,437 Residential real estate 876,652 843,101 Multi-family financing (1) 3,236,917 2,702,042 Healthcare financing (1) 1,262,424 826,157 Commercial and commercial real estate 695,158 520,199 Agricultural production and real estate 90,070 97,060 Consumer and margin loans 8,871 12,667 7,070,677 5,782,663 Less: ACL-Loans 37,474 31,344 Loans Receivable $ 7,033,203 $ 5,751,319 (1) In 2022, the Company started presenting these two loan types on separate lines for reporting purposes. In response to the COVID-19 global pandemic, the Coronavirus Aid, Relief and Economic Security Act (“CARES Act”) established the Paycheck Protection Program (“PPP”) to provide loans for eligible business/not-for-profits. These loans qualify for forgiveness when used for qualifying expenses during the appropriate period. Loans funded through the PPP are fully guaranteed by the U.S. government. As of June 30, 2022 all PPP loans have been forgiven. As of December 31, 2021, commercial and commercial real estate loans included PPP loans with principal balances of $7.0 million that had not yet been forgiven. Risk characteristics applicable to each segment of the loan portfolio are described as follows. Mortgage Warehouse Lines of Credit (MTG WHLOC): Under its warehouse program, the Company provides warehouse financing arrangements to approved mortgage companies for the origination and sale of residential mortgage loans and to a lesser extent multi-family loans. Agency eligible, governmental and jumbo residential mortgage loans that are secured by mortgages placed on existing one-to-four family dwellings may be originated or purchased and placed on each mortgage warehouse line. As a secured repurchase agreement, collateral pledged to the Company secures each individual mortgage until the lender sells the loan in the secondary market. A traditional secured warehouse line of credit typically carries a base interest rate of 30-day London Interbank Offered Rate (“LIBOR”) or the Federal Reserve’s Secured Overnight Financing Rate (“SOFR”), or mortgage note rate and a margin. Risk is evident if there is a change in the fair value of mortgage loans originated by mortgage bankers in warehouse, the sale of which is the expected source of repayment of the borrowings under a warehouse line of credit. Residential Real Estate Loans (RES RE): Real estate loans are secured by owner-occupied 1- 4 family residences. Repayment of residential real estate loans is primarily dependent on the personal income and credit rating of the borrowers. First-lien HELOC mortgages included in this segment typically carry a base rate of 30-day LIBOR or the One-Year Constant Maturity Treasury (“CMT”), plus a margin. Multi-Family Financing (MF FIN): Healthcare Financing (HC FIN): The healthcare financing portfolio includes customized loan products for independent living, assisted living, memory care and skilled nursing projects. A variety of loan products are available to accommodate rehabilitation, acquisition, and refinancing of healthcare properties. Credit risk in these loans are primarily driven by local demographics and the expertise of the operators of the facilities. Repayment of these loans may include permanent loans, sales of developed property or an interim loan commitment from the Company until permanent agency-eligible financing is obtained, as well as successful operation of a business or property and the borrower’s cash flows. Loans included in this segment typically carry a base rate of SOFR that adjusts on a monthly basis and a margin. Commercial Lending and Commercial Real Estate Loans (CML & CRE): The commercial lending and commercial real estate portfolio includes loans to commercial customers for use in financing working capital needs, equipment purchases and expansions, as well as loans to commercial customers to finance land and improvements. It also includes loans collateralized by servicing rights and loan sale proceeds of mortgage warehouse customers. The loans in this category are repaid primarily from the cash flow of a borrower’s principal business operation. Credit risk in these loans is driven by creditworthiness of a borrower and the economic conditions that impact the cash flow stability from business operations. PPP loans and Small Business Administration (“SBA”) loans are included in this category. Agricultural Production and Real Estate Loans (AG & AGRE): Agricultural production loans are generally comprised of seasonal operating lines of credit to grain farmers to plant and harvest corn and soybeans and term loans to fund the purchase of equipment. The Company also offers long term financing to purchase agricultural real estate. Specific underwriting standards have been established for agricultural-related loans including the establishment of projections for each operating year based on industry-developed estimates of farm input costs and expected commodity yields and prices. Operating lines are typically written for one year and secured by the crop and other farm assets as considered necessary. The Company is approved to sell agricultural loans in the secondary market through the Federal Agricultural Mortgage Corporation and uses this relationship to manage interest rate risk within the portfolio. Agricultural real estate loans included in this segment are typically structured with a one-year ARM, 3-year ARM or 5-year ARM CMT and a margin. Agriculture production, livestock, and equipment loans are structured with variable rates that are indexed to prime or fixed for terms not exceeding 5 years. Consumer and Margin Loans (CON & MAR): Consumer loans are those loans secured by household assets. Margin loans are those loans secured by marketable securities. The term and maximum amount for these loans are determined by considering the purpose of the loan, the margin (advance percentage against value) in all collateral, the primary source of repayment, and the borrower’s other related cash flow. ACL-Loans The Company adopted CECL on January 1, 2022. CECL replaces the previous “Allowance for Loan and Lease Losses” standard for measuring credit losses. Upon adoption of CECL, the difference in the two measurements was recorded in the ACL-Loans and retained earnings. The ACL-Loans is the Company’s estimate of expected credit losses. Loans receivable is presented net of the allowance to reflect the principal balance expected to be collected over the contractual term of the loans. This life of loan allowance is established through a provision for credit losses charged to net interest income as loans are recorded in the financial statements. The provision for a reporting period also reflects increases or decreases in the allowance related to changes in credit loss expectations. Actual credit losses are charged against the allowance when management believes the uncollectibility of a loan balance, or a portion thereof, is confirmed. Subsequent recoveries, if any, are credited to the allowance. The ACL-Loans is evaluated on a regular basis by management and is based upon management’s periodic review of the collectability of the loans considering relevant available information from internal and external sources, including historical experience, the nature and volume of the loan portfolio, adverse situations that may affect the borrower’s ability to repay, estimated value of any underlying collateral and prevailing economic conditions. The allowance also incorporates reasonable and supportable forecasts. There have been no changes to the credit quality components used to assess risk during the six months ended June 30, 2022. This evaluation is inherently subjective as it requires estimates that are susceptible to significant revision as more information becomes available. The level of the ACL is believed to be adequate to absorb innate expected future losses in the loan portfolio as of the measurement date. The ACL-Loans consists of individually evaluated loans and pooled loan components. The Company’s primary portfolio segmentation is by credit risk grade. Loans risk graded substandard and worse are individually evaluated for expected credit losses. For individually evaluated loans that are collateral dependent, an allowance is established when the fair value of the collateral, the loan’s obtainable market price, or the present value of expected future cash flows discounted at the loan’s effective interest rate, is lower than the carrying value of that loan. A loan is considered to be collateral dependent when repayment is expected to be provided substantially through the operation or the sale of the collateral. To calculate the allowance for expected credit losses on loans risk graded pass through special mention, the loan portfolio is segmented into 14 segments comprised of loans with similar risk characteristics. Loan Portfolio Segment ACL-Loans Methodology Ag loans Remaining Life Method Ag real estate loans Remaining Life Method Commercial loans Discounted Cash Flow Commercial real estate loans Discounted Cash Flow Consumer and margin loans Remaining Life Method HELOC loans Discounted Cash Flow Multi-family healthcare loans Discounted Cash Flow Multi-family non-management loans Discounted Cash Flow Multi-family construction loans Discounted Cash Flow Multi-family loans Discounted Cash Flow Residential real estate loans Discounted Cash Flow SBA commercial loans Discounted Cash Flow SBA real estate commercial loans Discounted Cash Flow Single-family warehouse lines of credit Remaining Life Method Loan characteristics used in determining the segmentation included the underlying collateral, type or purpose of the loan, and expected credit loss patterns. The estimation of expected credit losses for each segment is primarily based on historical credit loss experience. Given the Company’s modest historical credit loss experience, peer and industry data was incorporated into the measurement. Expected life of loan credit losses are quantified using discounted cash flows and remaining life methodologies. For the ten portfolio segments where the discounted cash flow method was employed, econometric models are utilized to determine a Probability of Default (“PD”). Macroeconomic factors utilized in the modeling process include the national unemployment rate and the home price index. A risk index was then utilized to predict the Loss Given Default (“LGD”). The PD is then multiplied by the LGD to determine the expected loss that is incorporated into the discounted cash flow calculations. Within the discount cash flow calculation, an effective yield of the instrument is calculated, net of the impacts of prepayment assumptions, and the instrument expected cash flows are then discounted at that effective yield to produce an instrument-level net present value of expected cash flows. An ACL is established for the difference between the instrument’s net present value and amortized cost basis. The remaining life method applies average loss rates for each segment to estimated loan balances for the remaining life of the segment. The estimate includes a four-quarter reasonable and supportable economic forecast period followed by an eight-quarter, straight-line reversion period to the historical mean for the remaining life of the loans. Model results are supplemented by qualitative adjustments for risk factors relevant in assessing the expected credit losses within the portfolio segments. These adjustments may increase or decrease the estimate of expected credit losses based upon the assessed level of risk for each qualitative factor. The various risks that are considered in making qualitative adjustments include (i) changes in the value of underlying collateral for collateral dependent loans, (ii) the effect of other external factors such as regulatory and legal requirements, the impact of (i) changes in national, regional and local economic conditions, (ii) changes in lending policies and procedures, (iii) changes in the volume and severity of past due loans, (iv) changes in the nature and volume of the loan portfolio, (v) changes in the experience, depth and ability of lending management, (vi) the existence and effect of any concentrations in credit, (vii) changes in the quality of the credit review function, The models utilized and the applicable qualitative adjustments require assumptions and management judgement that can be subjective in nature. The above measurement approach is also used to estimate the expected credit losses associated with unfunded loan commitments, which also incorporates expected utilization rates. The following tables present, by loan portfolio segment, the activity in the ACL-Loans for the three and six months ended June 30, 2022: For the Three Months Ended June 30, 2022 MTG WHLOC RES RE MF FIN HC FIN CML & CRE AG & AGRE CON & MAR TOTAL (In thousands) ACL-Loans Balance, beginning of period $ 1,941 $ 4,547 $ 15,131 $ 5,618 $ 4,102 $ 597 $ 166 $ 32,102 Provision for credit losses 481 363 1,233 2,318 474 (46) (55) 4,768 Loans charged to the allowance — — — — (32) — (15) (47) Recoveries of loans previously charged off — — — — 651 — — 651 Balance, end of period $ 2,422 $ 4,910 $ 16,364 $ 7,936 $ 5,195 $ 551 $ 96 $ 37,474 For the Six Months Ended June 30, 2022 MTG WHLOC RES RE MF FIN HC FIN CML & CRE AG & AGRE CON & MAR TOTAL (In thousands) ACL-Loans Balance, beginning of period $ 1,955 $ 4,170 $ 14,084 $ 4,461 $ 5,879 $ 657 $ 138 $ 31,344 Impact of adopting CECL 41 275 520 139 (1,277) (18) 21 (299) Provision for credit losses 426 465 1,760 3,336 905 (88) (55) 6,749 Loans charged to the allowance — — — — (963) — (15) (978) Recoveries of loans previously charged off — — — — 651 — 7 658 Balance, end of period $ 2,422 $ 4,910 $ 16,364 $ 7,936 $ 5,195 $ 551 $ 96 $ 37,474 The Company recorded a provision for credit losses of $6.2 million for the three months ended June 30, 2022. The $6.2 million provision for credit losses consisted of $4.8 million for the ACL-Loans, $0.2 million for the ACL-OBCE’s and $1.2 million for the contingent reserve related to the Freddie Mac-sponsored Q-series securitization transaction. The Company recorded a provision for credit losses of $8.7 million for the six months ended June 30, 2022. The $8.7 million provision for credit losses consisted of $6.7 million for the ACL-Loans, $0.8 million for the ACL-OBCE’s, and $1.2 million for the contingent reserve related to the Freddie Mac-sponsored Q-series securitization transaction. Prior to the adoption of CECL, the Company maintained an allowance for loan losses in accordance with the incurred loss model as disclosed in the Company’s 2021 Annual Report on Form 10-K. The following tables present the allowance for loan losses for the three and six months ended June 30, 2021: For the Three Months Ended June 30, 2021 MTG WHLOC RES RE MF FIN HC FIN CML & CRE AG & AGRE CON & MAR TOTAL (In thousands) Allowance for loan losses Balance, beginning of period $ 3,321 $ 3,600 $ 13,396 $ 3,740 $ 4,264 $ 632 $ 138 $ 29,091 Provision for credit losses (386) 371 (1,718) 364 1,059 (21) 16 (315) Loans charged to the allowance — (2) — — (84) — — (86) Recoveries of loans previously charged off — — — — — — 6 6 Balance, end of period $ 2,935 $ 3,969 $ 11,678 $ 4,104 $ 5,239 $ 611 $ 160 $ 28,696 For the Six Months Ended June 30, 2021 MTG WHLOC RES RE MF FIN HC FIN CML & CRE AG & AGRE CON & MAR TOTAL (In thousands) Allowance for loan losses Balance, beginning of period $ 4,018 $ 3,334 $ 12,041 $ 2,690 $ 4,641 $ 636 $ 140 $ 27,500 Provision for credit losses (1,083) 637 (363) 1,414 750 (25) 18 1,348 Loans charged to the allowance — (2) — — (152) — (6) (160) Recoveries of loans previously charged off — — — — — — 8 8 Balance, end of period $ 2,935 $ 3,969 $ 11,678 $ 4,104 $ 5,239 $ 611 $ 160 $ 28,696 The following table presents the allowance for loan losses and the recorded investment in loans and impairment method as of December 31, 2021: December 31, 2021 MTG WHLOC RES RE MF FIN HC FIN CML & CRE AG & AGRE CON & MAR TOTAL (In thousands) Allowance for loan losses Balance, December 31, 2021 $ 1,955 $ 4,170 $ 14,084 $ 4,461 $ 5,879 $ 657 $ 138 $ 31,344 Ending balance: individually evaluated for impairment $ — $ 16 $ — $ — $ 867 $ — $ 7 $ 890 Ending balance: collectively evaluated for impairment $ 1,955 $ 4,154 $ 14,084 $ 4,461 $ 5,012 $ 657 $ 131 $ 30,454 Loans Balance, December 31, 2021 $ 781,437 $ 843,101 $ 2,702,042 $ 826,157 $ 520,199 $ 97,060 $ 12,667 $ 5,782,663 Ending balance individually evaluated for impairment $ — $ 419 $ 36,760 $ — $ 6,055 $ 158 $ 13 $ 43,405 Ending balance collectively evaluated for impairment $ 781,437 $ 842,682 $ 2,665,282 $ 826,157 $ 514,144 $ 96,902 $ 12,654 $ 5,739,258 The below table presents the amortized cost basis and ACL-Loans allocated for collateral dependent loans, which are individually evaluated to determine expected credit losses: June 30, 2022 Real Estate Accounts Receivable / Equipment Other Total ACL-Loans Allocation (In thousands) RES RE $ 353 $ — $ 6 $ 359 $ 29 MF FIN 36,760 — — 36,760 187 CML & CRE 134 4,935 236 5,305 92 AG & AGRE 158 — — 158 1 CON & MAR — — 3 3 — Total collateral dependent loans $ 37,405 $ 4,935 $ 245 $ 42,585 $ 309 There has been no significant changes to the types of collateral securing the Company’s collateral dependent loans compared to June 30, 2021. Internal Risk Categories In adherence with policy, the Company uses the following internal risk grading categories and definitions for loans: Average or above Acceptable – Special Mention (Watch) – This is a loan that is sound and collectable but contains potential risk. Loans classified as special mention have a potential weakness that deserves management’s close attention. If left uncorrected, these potential weaknesses may result in deterioration of the repayment prospects for the loan or of the institution’s credit position at some future date. Substandard Doubtful The following tables present the credit risk profile of the Company’s loan portfolio based on internal risk rating category as of June 30, 2022 and December 31, 2021: 2022 2021 2020 2019 2018 Prior Revolving Loans TOTAL (In thousands) MTG WHLOC Acceptable and Above $ — $ — $ — $ — $ — $ — $ 900,585 $ 900,585 Total $ — $ — $ — $ — $ — $ — $ 900,585 $ 900,585 RES RE Acceptable and Above 10,316 36,482 49,380 3,327 865 10,439 764,571 875,380 Special Mention (Watch) — — — 61 74 779 — 914 Substandard — — — — — 358 — 358 Total $ 10,316 $ 36,482 $ 49,380 $ 3,388 $ 939 $ 11,576 $ 764,571 $ 876,652 MF FIN Acceptable and Above 874,093 1,049,580 305,633 71,513 12,245 7,739 852,442 3,173,245 Special Mention (Watch) 14,614 12,298 — — — — — 26,912 Substandard 36,760 — — — — — — 36,760 Total $ 925,467 $ 1,061,878 $ 305,633 $ 71,513 $ 12,245 $ 7,739 $ 852,442 $ 3,236,917 HC FIN Acceptable and Above 486,989 331,862 183,035 17,186 — — 144,812 1,163,884 Special Mention (Watch) — 29,462 62,373 6,705 — — — 98,540 Total $ 486,989 $ 361,324 $ 245,408 $ 23,891 $ — $ — $ 144,812 $ 1,262,424 CML & CRE Acceptable and Above 66,173 85,267 31,966 49,946 13,850 15,489 424,308 686,999 Special Mention (Watch) 48 21 1,448 129 — 234 973 2,853 Substandard — 2,000 — 107 175 282 2,742 5,306 Total $ 66,221 $ 87,288 $ 33,414 $ 50,182 $ 14,025 $ 16,005 $ 428,023 $ 695,158 AG & AGRE Acceptable and Above 8,358 7,984 15,952 6,291 3,457 21,141 24,779 87,962 Special Mention (Watch) 14 64 719 431 288 390 44 1,950 Substandard — — — — — 158 — 158 Total $ 8,372 $ 8,048 $ 16,671 $ 6,722 $ 3,745 $ 21,689 $ 24,823 $ 90,070 CON & MAR Acceptable and Above 240 674 394 140 4,743 20 2,638 8,849 Special Mention (Watch) — — 16 — — 3 — 19 Substandard — — — — — 3 — 3 Total $ 240 $ 674 $ 410 $ 140 $ 4,743 $ 26 $ 2,638 $ 8,871 Total Acceptable and Above $ 1,446,169 $ 1,511,849 $ 586,360 $ 148,403 $ 35,160 $ 54,828 $ 3,114,135 $ 6,896,904 Total Special Mention (Watch) $ 14,676 $ 41,845 $ 64,556 $ 7,326 $ 362 $ 1,406 $ 1,017 $ 131,188 Total Substandard $ 36,760 $ 2,000 $ — $ 107 $ 175 $ 801 $ 2,742 $ 42,585 Total Loans $ 1,497,605 $ 1,555,694 $ 650,916 $ 155,836 $ 35,697 $ 57,035 $ 3,117,894 $ 7,070,677 December 31, 2021 MTG WHLOC RES RE MF FIN HC FIN CML & CRE AG & AGRE CON & MAR TOTAL (In thousands) Special Mention (Watch) $ — $ 946 $ 27,155 $ 66,406 $ 2,483 $ 3,820 $ 21 $ 100,831 Substandard — 419 36,760 — 6,055 158 13 43,405 Acceptable and Above 781,437 841,736 2,638,127 759,751 511,661 93,082 12,633 5,638,427 Total $ 781,437 $ 843,101 $ 2,702,042 $ 826,157 $ 520,199 $ 97,060 $ 12,667 $ 5,782,663 The Company evaluates the loan risk grading system definitions and ACL-Loans methodology on an ongoing basis. No significant changes were made to either during the past year. Delinquent Loans The following tables present the Company’s loan portfolio aging analysis of the recorded investment in loans as of June 30, 2022 and December 31, 2021. There was June 30, 2022 30-59 Days 60-89 Days Greater Than Total Total Past Due Past Due 90 Days Past Due Current Loans (In thousands) MTG WHLOC $ — $ — $ — $ — $ 900,585 $ 900,585 RES RE 307 216 176 699 875,953 876,652 MF FIN — — — — 3,236,917 3,236,917 HC FIN — — — — 1,262,424 1,262,424 CML & CRE — — 4,083 4,083 691,075 695,158 AG & AGRE — — — — 90,070 90,070 CON & MAR 39 42 3 84 8,787 8,871 $ 346 $ 258 $ 4,262 $ 4,866 $ 7,065,811 $ 7,070,677 December 31, 2021 30-59 Days 60-89 Days Greater Than Total Total Past Due Past Due 90 Days Past Due Current Loans (In thousands) MTG WHLOC $ — $ — $ — $ — $ 781,437 $ 781,437 RES RE 1,252 287 186 1,725 841,376 843,101 MF FIN — — — — 2,702,042 2,702,042 HC FIN — — — — 826,157 826,157 CML & CRE 591 8 149 748 519,451 520,199 AG & AGRE 37 21 — 58 97,002 97,060 CON & MAR 43 5 40 88 12,579 12,667 $ 1,923 $ 321 $ 375 $ 2,619 $ 5,780,044 $ 5,782,663 Impaired Loans The following table presents impaired loans and specific valuation allowance information based on class level as of December 31, 2021: December 31, 2021 MTG WHLOC RES RE MF FIN HC FIN CML & CRE AG & AGRE CON & MAR TOTAL (In thousands) Impaired loans without a specific allowance: Recorded investment $ — $ 372 $ 36,760 $ — $ 3,912 $ 158 $ 4 $ 41,206 Unpaid principal balance — 372 36,760 — 3,912 158 4 41,206 Impaired loans with a specific allowance: — — Recorded investment — 47 — — 2,143 — 9 2,199 Unpaid principal balance — 47 — — 2,143 — 9 2,199 Specific allowance — 16 — — 867 — 7 890 Total impaired loans: Recorded investment — 419 36,760 — 6,055 158 13 43,405 Unpaid principal balance — 419 36,760 — 6,055 158 13 43,405 Specific allowance — 16 — — 867 — 7 890 The following table presents by portfolio class, information related to the average recorded investment and interest income recognized on impaired loans for the three and six months ended June 30, 2021: For the Three Months Ended June 30, 2021 MTG WHLOC RES RE MF FIN HC FIN CML & CRE AG & AGRE CON & MAR TOTAL Average recorded investment in impaired loans — $ 2,201 $ — $ — $ 6,113 $ 175 $ 6 $ 8,495 Interest income recognized — 16 — — 55 — — 71 For the Six Months Ended June 30, 2021 CML & AG & CON & RES RE MF RE CRE AGRE MAR TOTAL Average recorded investment in impaired loans — $ 2,442 $ — $ — $ 7,254 $ 1,000 $ 7 $ 10,703 Interest income recognized — 27 — — 259 — — 286 Nonperforming Loans Nonaccrual loans, including TDRs that have not met the six-month minimum performance criterion, are reported as nonperforming loans. For all loan classes, it is the Company’s policy to have any restructured loans which are on nonaccrual status prior to being restructured remain on nonaccrual status until three months of satisfactory borrower performance, at which time management would consider its return to accrual status. A loan is generally classified as nonaccrual when the Company believes that receipt of principal and interest is doubtful under the terms of the loan agreement. Most generally, this is at 90 or more days past due. The amount of interest income recognized on nonaccrual financial assets during the six months ended June 30, 2022 was immaterial. The following table presents the Company’s nonaccrual loans and loans past due 90 days or more and still accruing at June 30, 2022 and December 31, 2021. June 30, December 31, 2022 2021 Total Loans > Total Loans > 90 Days & 90 Days & Nonaccrual Accruing Nonaccrual Accruing (In thousands) RES RE $ 347 $ — $ 362 $ 22 CML & CRE 4,305 — — 149 AG & AGRE 158 — 158 30 CON & MAR 3 — 4 36 $ 4,813 $ — $ 524 $ 237 The Company did not have any nonperforming loans without an estimated ACL at June 30, 2022. No troubled loans were modified during the three or six months ended June 30, 2022 or 2021. restructured loans defaulted during the three or six months ended June 30, 2022 or 2021. Loan modifications or forbearances related to the COVID-19 pandemic will generally not be considered TDRs. The CARES Act included several provisions designed to help financial institutions like the Company in working with their customers. Section 4013 of the CARES Act, as extended, allows a financial institution to elect to suspend generally accepted accounting principles and regulatory determinations with respect to qualifying loan modifications related to COVID-19 that would otherwise be categorized as a TDR until January 1, 2022. The Company has taken advantage of this provision to extend certain payment modifications to loan customers in need. As of June 30, 2022, the Company has only There were no residential loans in process of foreclosure as of June 30, 2022 and December 31, 2021. Loan Sales for Freddie Mac Q Series Securitizations 2022 Activity On May 5, 2022, the Company entered into an arrangement t |